Cemex, S.A.B. de C.V. Sponsored ADR (CX)

Stockholders Equity

$12.53B

Quarterly · Period ending: · USD

CX logo

CX Stockholders Equity

Latest reported$12.53B
CX Quarterly Shareholders Equity ($4.17B → $12.53B)
High-resolution chart · PNG

CX stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cemex, S.A.B. de C.V. Sponsored ADR Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
12,530,021,000
13,136,921,000
13,314,270,484
13,603,633,218
13,360,519,000
12,935,192,000
12,176,000,000
12,099,018,000
11,783,208,000
11,763,282,000
11,052,000,000
12,169,660,000
12,143,782,000
11,818,315,000
10,501,000,000
10,495,518,000
10,121,646,000
9,827,000,000
9,539,266,000
9,989,385,000
8,685,430,000
8,075,000,000
7,402,971,000
8,792,022,000
8,783,689,000
9,296,000,000
9,557,242,000
9,510,881,000
9,245,801,000
9,305,000,000
9,839,128,788
9,645,329,687
9,428,326,731
9,001,149,983
9,506,721,422
9,330,262,683
8,587,030,420
7,912,676,261
8,537,427,338
8,224,704,810
8,183,672,393
8,308,106,192
8,236,119,368
8,765,031,610
8,430,539,134
8,899,102,371
10,158,369,561
10,480,234,874
10,290,726,801
10,238,414,530
10,759,277,282
10,751,541,782
11,157,076,432
10,992,342,626
12,195,560,393
11,239,723,799
11,522,797,421
11,140,472,479
13,991,011,955
15,544,974,212
15,964,258,683
15,746,212,981
16,115,531,205
15,985,749,321
16,118,910,750
16,346,147,966
15,882,684,815
13,903,595,872
13,420,362,620
13,862,460,017
20,217,249,714
16,499,490,000
19,601,365,000
14,942,000,000
15,446,774,000
13,898,824,000
13,118,130,000
12,859,000,000
12,017,635,000
11,033,762,000
10,221,329,000
9,837,000,000
9,503,001,000
8,857,715,000
8,099,379,000
7,829,260,000
7,097,304,000
7,097,304,000
6,383,484,000
6,241,401,000
6,197,538,000
6,004,739,000
5,511,238,000
5,739,897,000
5,929,436,000
6,155,779,000
6,759,665,000
6,185,033,000
5,698,576,000
5,918,602,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.